Clinical Definition

Efficacy data includes:

  • Residual AHI: Remaining respiratory events during therapy
  • Leak Rates: Mask leak levels during therapy
  • Pressure Levels: Pressures delivered during therapy
  • Event Distribution: Types and timing of residual events
  • Therapy Optimization: Data to guide treatment adjustments

Efficacy data is automatically collected by PAP devices and provides objective measures of treatment effectiveness.

Etymology & History

Efficacy data collection became possible with advanced PAP devices capable of detecting and analyzing respiratory events during therapy.

Reference Values & Interpretation

Normal Values

Good efficacy data shows residual AHI <5, leak rates <24 L/min, and appropriate pressure levels maintaining therapy effectiveness.

Abnormal Values

Poor efficacy data shows high residual AHI, excessive leaks, or inadequate pressure levels, indicating therapy problems requiring intervention.

How It's Measured

Efficacy data is automatically collected by PAP devices using internal sensors and algorithms to detect events and assess therapy effectiveness.

Role in Diagnosis

Efficacy data is used to assess therapy effectiveness and identify problems that may require pressure adjustments or other interventions.

Role in Treatment

Efficacy data is essential for PAP therapy optimization, providing objective measures of treatment effectiveness and guiding clinical decisions.

Associated Conditions

residual-ahi|leak-rates|therapy-effectiveness|treatment-optimization

">

Clinical Guidelines

[{"guideline_title":"AASM Clinical Practice Guideline for PAP Therapy Monitoring","guideline_link":"/clinical/guidelines/aasm-pap-monitoring/"}]

Latest Research & Updates

AI-Updated Weekly

Recent advances in efficacy data include more detailed event analysis, automated therapy recommendations, and integration with clinical decision support systems.